Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR Monoclonal Antibody

NCT03146338 is registered in ClinicalTrials.gov with Weprom as lead sponsor.

NCT NCT03146338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03146338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR Monoclonal Antibody
Lead sponsor
Weprom
Phase
Not applicable
Overall status
Unknown status
Start date
July 4, 2017
Completion date
January 4, 2023
Enrollment
106 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer, metastatic head and neck cancer